The present randomized clinical trial is aimed at evaluating the efficacy of recombinant human platelet-derived growth factor in combination with collagen matrix for the treatment of multiple adjacent gingival recessions
Despite the fact that gingival recession is most often a generalized condition rather than being localized to a single tooth, most of the data currently found in the literature pertains to the treatment of localized gingival recessions. The gold standard treatment for this condition involves the use of an autogenous connective tissue graft, that is associated with increased patient morbidity. Biomaterials have progressively gained popularity due to their advantages when compared to autogenous grafts, such as unrestricted availability, avoidance of a secondary surgical site, reduction of the surgical time, and the patient's preference. Collagen matrix is one of the most used soft tissue substitute for the treatment of gingival recessions. Combining this scaffold material with a growth factor could enhance its outcomes. In particular, root coverage using platelet-derived growth factor can also promote regeneration of new cementum, periodontal ligament and bone. Therefore, the aim of the present study is to investigate the effect of platelet-derived growth factor in combination with collagen matrix outcomes for the treatment of multiple adjacent gingival recessions.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Enrollment
30
Treatment of multiple adjacent gingival recession using a coronally advanced flap
University of Michigan School of Dentistry
Ann Arbor, Michigan, United States
Mean Root Coverage
amount of recession reduction compared to the baseline recession depth
Time frame: 6 months
Keratinized tissue width gain
amount of keratinized tissue width gain from the baseline
Time frame: 6 months
Gingival thickness gain
amount of gingival thickness gain from the baseline
Time frame: 6 months
3D volumetric changes
Soft tissue volumetric variation evaluated with digital softwares
Time frame: 6 months
Tissue perfusion variations
Tissue perfusion variations compared to baseline at the different follow-up using ultrasonography
Time frame: 6 months
Patient-related outcomes
Patient self reported perception of the procedure in terms of morbidity, satisfaction and esthetic outcomes. Visual analogue scales (from 0 to 100) will be used to assess these outcomes
Time frame: 6 months
Esthetic outcomes
evaluated using the root coverage esthetic score (from 0 to 10)
Time frame: 6 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.